380 related articles for article (PubMed ID: 31452013)
1. Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).
Khalili A; Craigie M; Donadoni M; Sariyer IK
J Neuroimmune Pharmacol; 2019 Dec; 14(4):649-660. PubMed ID: 31452013
[TBL] [Abstract][Full Text] [Related]
2. Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.
Bellizzi A; Nardis C; Anzivino E; Rodìo D; Fioriti D; Mischitelli M; Chiarini F; Pietropaolo V
J Neurovirol; 2012 Feb; 18(1):1-11. PubMed ID: 22290500
[TBL] [Abstract][Full Text] [Related]
3. Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy.
Wollebo HS; Safak M; Del Valle L; Khalili K; White MK
J Neuroimmunol; 2011 Apr; 233(1-2):46-53. PubMed ID: 21185609
[TBL] [Abstract][Full Text] [Related]
4. Immune surveillance and response to JC virus infection and PML.
Beltrami S; Gordon J
J Neurovirol; 2014 Apr; 20(2):137-49. PubMed ID: 24297501
[TBL] [Abstract][Full Text] [Related]
5. Human polyomavirus JC latency and reactivation status in blood of HIV-1-positive immunocompromised patients with and without progressive multifocal leukoencephalopathy.
Andréoletti L; Dubois V; Lescieux A; Dewilde A; Bocket L; Fleury HJ; Wattré P
AIDS; 1999 Aug; 13(12):1469-75. PubMed ID: 10465069
[TBL] [Abstract][Full Text] [Related]
6. New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy.
Bellizzi A; Anzivino E; Rodio DM; Palamara AT; Nencioni L; Pietropaolo V
Clin Dev Immunol; 2013; 2013():839719. PubMed ID: 23690827
[TBL] [Abstract][Full Text] [Related]
7. Immunology of progressive multifocal leukoencephalopathy.
Jelcic I; Jelcic I; Faigle W; Sospedra M; Martin R
J Neurovirol; 2015 Dec; 21(6):614-22. PubMed ID: 25740538
[TBL] [Abstract][Full Text] [Related]
8. JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?
Diotti RA; Nakanishi A; Clementi N; Mancini N; Criscuolo E; Solforosi L; Clementi M
Clin Dev Immunol; 2013; 2013():967581. PubMed ID: 23878587
[TBL] [Abstract][Full Text] [Related]
9. JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review.
Harypursat V; Zhou Y; Tang S; Chen Y
AIDS Res Ther; 2020 Jul; 17(1):37. PubMed ID: 32631361
[TBL] [Abstract][Full Text] [Related]
10. Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation.
Tan CS; Broge TA; Ngo L; Gheuens S; Viscidi R; Bord E; Rosenblatt J; Wong M; Avigan D; Koralnik IJ
Biol Blood Marrow Transplant; 2014 Jul; 20(7):992-9. PubMed ID: 24680976
[TBL] [Abstract][Full Text] [Related]
11. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology and immunoregulation of human neurotropic JC virus in CNS.
Sweet TM; Del Valle L; Khalili K
J Cell Physiol; 2002 Jun; 191(3):249-56. PubMed ID: 12012320
[TBL] [Abstract][Full Text] [Related]
13. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.
Koralnik IJ; Du Pasquier RA; Letvin NL
J Virol; 2001 Apr; 75(7):3483-7. PubMed ID: 11238876
[TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal leukoencephalopathy: new concepts.
Lima MA
Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
[TBL] [Abstract][Full Text] [Related]
15. Neuroimmune Regulation of JC Virus by Intracellular and Extracellular Agnoprotein.
Craigie M; Cicalese S; Sariyer IK
J Neuroimmune Pharmacol; 2018 Jun; 13(2):126-142. PubMed ID: 29159704
[TBL] [Abstract][Full Text] [Related]
16. Expression of Signaling Molecules in Progressive Multifocal Leukoencephalopathy.
Wollebo HS; Cotto B; Adiga R; Langford D; White MK
Curr HIV Res; 2016; 14(1):47-53. PubMed ID: 26531763
[TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal leukoencephalopathy: JC virus induced demyelination in the immune compromised host.
Hou J; Major EO
J Neurovirol; 2000 May; 6 Suppl 2():S98-S100. PubMed ID: 10871795
[TBL] [Abstract][Full Text] [Related]
18. JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy.
Du Pasquier RA; Clark KW; Smith PS; Joseph JT; Mazullo JM; De Girolami U; Letvin NL; Koralnik IJ
J Neurovirol; 2001 Aug; 7(4):318-22. PubMed ID: 11517410
[TBL] [Abstract][Full Text] [Related]
19. Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1.
Chen G; Gorelik L; Simon KJ; Pavlenco A; Cheung A; Brickelmaier M; Chen LL; Jin P; Weinreb PH; Sidhu SS
MAbs; 2015; 7(4):681-92. PubMed ID: 25879139
[TBL] [Abstract][Full Text] [Related]
20. Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors.
Tan CS; Ghofrani J; Geiger E; Koralnik IJ; Jost S
J Acquir Immune Defic Syndr; 2019 Oct; 82(2):220-224. PubMed ID: 31513076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
